{"transactions":[{"id":939997,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-13T21:10:03.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":16410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date."}],"balance_after":16410,"derivative":{"exercise_price":1.1,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":16410},"source":{"system":"sec-edgar","filing":"0001493152-26-002034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226002034/ownership.xml","form_type":"4"}},{"id":1387505,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-11T20:05:52.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":14924,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan."}],"balance_after":14924,"source":{"system":"sec-edgar","filing":"0001493152-24-040898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315224040898/ownership.xml","form_type":"4"}},{"id":1825673,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-20T20:05:30.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":13567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date."}],"balance_after":13567,"derivative":{"exercise_price":2.67,"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":13567},"source":{"system":"sec-edgar","filing":"0001493152-23-025085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315223025085/ownership.xml","form_type":"4"}},{"id":2195558,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-03T20:51:21.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":148000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date."}],"balance_after":148000,"derivative":{"exercise_price":0.42,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":148000},"source":{"system":"sec-edgar","filing":"0001493152-22-021187","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315222021187/ownership.xml","form_type":"4"}},{"id":2629136,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-20T20:05:38.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date."}],"balance_after":74000,"derivative":{"exercise_price":1.11,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001493152-21-017324","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315221017324/ownership.xml","form_type":"4"}},{"id":3100775,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-24T22:50:33.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: 28,000 stock options will vest on the one year anniversary of the grant date and the remaining 28,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021."}],"balance_after":56000,"derivative":{"exercise_price":1.33,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001493152-20-011751","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315220011751/ownership.xml","form_type":"4"}},{"id":3211784,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T10:03:04.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":500,"price":1.5101,"value":755.05,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-20-018669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120018669/doc4.xml","form_type":"4"}},{"id":3229062,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T18:51:23.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":500,"price":1.47,"value":735.0,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0001209191-20-015941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120015941/doc4.xml","form_type":"4"}},{"id":3315544,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":69435,"kind":"person","name":"Japour Anthony J","position":1,"cik":"0001773088","reported_name":"Japour Anthony J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T21:37:39.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":1.49,"exercise_date":"2021-01-06","expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-002542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120002542/doc4.xml","form_type":"4"}}]}